Jansitin Duo

Metformin Hydrochloride and Sitagliptin, the active ingredient in Jansitin Duo, is a Biguanide/DPP‑4 inhibitor combination presented as a tablet for oral use. It treats type 2 diabetes mellitus in adult patients when diet and exercise are insufficient to achieve glycaemic control. The formulation combines two mechanisms to lower blood glucose levels, offering a convenient single‑pill regimen.

GNH USA supplies Jansitin Duo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across all markets.

Jansitin Duo, a combination antidiabetic medication, is indicated for the management of type 2 diabetes mellitus.

- Type 2 diabetes mellitus: improves glycaemic control when diet, exercise, and monotherapy are insufficient. - Adjunct to other oral antidiabetics